Param Capital
Family office and investment vehicle of Mukul Agrawal, founded in 1993. Mukul's disclosed listed equity book stood at ~Rs 6,604 cr across 73 stocks as of Q3 FY26, with healthcare and pharma the largest sector concentration: Neuland Labs, Zota Health Care, Onesource Specialty Pharma, Dishman Carbogen Amcis, Strides Pharma. Param Capital is the entity behind his bulk-deal activity in small and midcaps.
November 2026 update
As of November 2026, Param Capital holds a stake of over 1% in 1 listed company. The largest by value is Lumax Industries. About 100% is in auto companies. In the last 30 days, Param Capital made 1 move, including 1 new position.
Latest open move, 22 Jul 2026: Param Capital no longer appears on Lumax Industries Limited's disclosed shareholder list, following its last reported 1.34 percent stake, indicating either a complete sale or a reduction below the 1 percent disclosure threshold.
Questions about Param Capital
What stocks does Param Capital own?
As of November 2026, Param Capital holds a stake of over 1% in 1 listed company. The largest by value is Lumax Industries. The full list is under Holdings on this page.
What did Param Capital buy or sell recently?
Param Capital no longer appears on Lumax Industries Limited's disclosed shareholder list, following its last reported 1.34 percent stake, indicating either a complete sale or a reduction below the 1 percent disclosure threshold. (22 Jul 2026)
How can I track Param Capital's moves?
Follow Param Capital on WhaleWatch to get an alert the same day a new move appears.